Haemonetics Ownership | Who Owns Haemonetics?

Overview Forecast RevenueFinancials Chart Transcripts

Haemonetics Ownership Summary

Haemonetics is owned by 113.10% institutional investors, 1.15% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 13.23% of HAE shares. Neuberger Berman Genesis Inv is the top mutual fund, with 4.39% of its assets in Haemonetics shares.

HAE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Haemonetics	113.10%	1.15%	-14.24%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Medical Instruments & Supplies Stocks	56.90%	14.82%	28.28%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	6.36M	13.23%	$474.88M
Blackrock	5.96M	11.73%	$493.00M
Vanguard group	5.18M	10.18%	$404.41M
Neuberger berman group	4.42M	8.68%	$345.01M
Wellington management group llp	3.94M	7.74%	$307.65M
State street	1.85M	3.64%	$153.09M
River road asset management	1.66M	3.44%	$122.59M
T. rowe price investment management	1.59M	3.31%	$118.99M
Royce & associates lp	1.27M	2.64%	$94.83M
Capital research global investors	1.14M	2.37%	$84.98M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sg capital management	906.89K	4.68%	$67.66M
Tradelink capital	13.97K	3.69%	$1.04M
Qsv equity investors	20.79K	1.62%	$1.55M
Riverwater partners	44.92K	1.58%	$3.35M
Intrinsic edge capital management	150.35K	1.57%	$11.22M
River road asset management	1.66M	1.56%	$122.59M
Aristotle capital boston	362.95K	1.38%	$27.08M
Beacon investment advisors	30.77K	0.98%	$2.27M
Royce & associates lp	1.27M	0.97%	$94.83M
Schwartz investment counsel	372.50K	0.92%	$27.79M

Top Buyers

Holder	Shares	% Assets	Change
Barrow hanley mewhinney & strauss	480.83K	0.12%	480.83K
Norges bank	420.12K	0.00%	420.12K
Neuberger berman group	4.42M	0.27%	392.24K
Voya investment management	316.95K	0.03%	282.52K
River road asset management	1.66M	1.56%	260.62K

Top Sellers

Holder	Shares	% Assets	Change
Thrivent financial for lutherans	-	-	-1.26M
Westfield capital management co lp	-	-	-805.92K
T. rowe price investment management	1.59M	0.08%	-600.70K
Capital research global investors	1.14M	0.02%	-438.28K
Wellington management group llp	3.94M	0.06%	-261.34K

New Positions

Holder	Shares	% Assets	Change	Value
Barrow hanley mewhinney & strauss	480.83K	0.12%	480.83K	$35.88M
Norges bank	420.12K	0.00%	420.12K	$32.80M
Neo ivy capital management	40.78K	0.66%	40.78K	$3.37M
Algert global	30.52K	0.05%	30.52K	$2.28M
Hap trading	22.00K	0.02%	22.00K	$134.90K

Sold Out

Holder	Change
Colonial trust co / sc	-1.00
Natixis	-1.00
Tfc financial management	-1.00
Rfp financial group	-1.00
Claris advisors, llc / mo /	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	309	-6.93%	54,411,783	0.83%	113	0.98%	158	-12.22%	103	-
Mar 31, 2025	330	-0.30%	53,955,084	-5.19%	107	0.84%	180	4.05%	102	7.37%
Dec 31, 2024	177	-44.51%	31,118,376	-43.80%	61	0.52%	94	-38.16%	49	-56.25%
Sep 30, 2024	317	-2.46%	55,196,535	-1.16%	108	0.90%	152	-9.52%	111	4.72%
Jun 30, 2024	321	6.29%	55,777,438	10.02%	109	1.10%	164	13.89%	106	-7.83%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Neuberger Berman Genesis Inv	2.11M	4.39%	-80.85K
iShares Core S&P Mid-Cap ETF	1.64M	3.40%	-2.97K
Vanguard US Total Market Shares ETF	1.60M	3.19%	1.18K
Vanguard Total Stock Mkt Idx Inv	1.52M	3.16%	-31.96K
iShares Russell 2000 ETF	1.19M	2.47%	-22.57K
Vanguard Explorer Inv	1.18M	2.46%	-
Vanguard Small Cap Index	1.17M	2.42%	-7.06K
T. Rowe Price US Smlr Cm Eq A USD	1.06M	2.22%	-54.63K
American Funds SMALLCAP World A	1.01M	2.11%	-374.17K
VA CollegeAmerica Amcap 529A	901.53K	1.79%	-187.69K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 26, 2024	Strong Stewart W	President, Global Hospital	Sell	$393.04K
Jul 12, 2024	Lingamneni Anila	EVP, Chief Technology Officer	Sell	$7.11K
Jul 11, 2024	Lingamneni Anila	EVP, Chief Technology Officer	Sell	$192.24K
May 29, 2024	Basil Michelle L	EVP and General Counsel	Sell	$362.61K
May 29, 2024	Basil Michelle L	EVP and General Counsel	Sell	$781.60K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2024 Q4	-	-
2024 Q3	-	3
2024 Q2	-	12

HAE Ownership FAQ

Who Owns Haemonetics?

Haemonetics shareholders are primarily institutional investors at 113.10%, followed by 1.15% insiders and -14.25% retail investors. The average institutional ownership in Haemonetics's industry, Medical Instruments & Supplies Stocks, is 56.90%, which Haemonetics exceeds.

Who owns the most shares of Haemonetics?

Haemonetics’s largest shareholders are Blackrock funding, inc. /de (6.36M shares, 13.23%), Blackrock (5.96M shares, 11.73%), and Vanguard group (5.18M shares, 10.18%). Together, they hold 35.14% of Haemonetics’s total shares outstanding.

Does Blackrock own Haemonetics?

Yes, BlackRock owns 11.73% of Haemonetics, totaling 5.96M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 493M$. In the last quarter, BlackRock decreased its holdings by -25.268K shares, a -0.42% change.

Who is Haemonetics’s biggest shareholder by percentage of total assets invested?

Sg capital management is Haemonetics’s biggest shareholder by percentage of total assets invested, with 4.68% of its assets in 906.89K Haemonetics shares, valued at 67.66M$.

Who is the top mutual fund holder of Haemonetics shares?

Neuberger Berman Genesis Inv is the top mutual fund holder of Haemonetics shares, with 4.39% of its total shares outstanding invested in 2.11M Haemonetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools